Title : Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study.

Pub. Date : 2008

PMID : 18172786






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Celecoxib single agent could also inhibit AKT and ERK pathway in NSCLC, even the EGFR expression under high concentration treatment. Celecoxib epidermal growth factor receptor Homo sapiens